Separation-induced ultrasonic vocalization in rat pups: Further pharmacological characterization

Pharmacology Biochemistry and Behavior

Volumn 82, Issue 4, 2005, Pages 652-657

  Iijima, Michihiko ^a   Chaki, Shigeyuki ^a  

^a TAISHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Anxiety; Corticotropin releasing factor; Maternal separation; Ultrasonic vocalization; Vasopressin

Indexed keywords

1 [5 CHLORO 1 (2,4 DIMETHOXYLPHENYLSULFONYL) 2,3 DIHYDRO 3 (2 METHOXYPHENYL) 2 OXO 1H INDOL 3 YL] 4 HYDROXY N,N DIMETHYL 2 PYRROLIDINECARBOXAMIDE; 2 METHYL 6 (PHENYLETHYNYL)PYRIDINE; BUTYL[2,5 DIMETHYL 7 (2,4,6 TRIMETHYLPHENYL) 7H PYRROLO[2,3 D]PYRIMIDIN 4 YL]ETHYLAMINE; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; DESIPRAMINE; FLUVOXAMINE; MILNACIPRAN; PAROXETINE; VASOPRESSIN V1 RECEPTOR;

ANIMAL EXPERIMENT; ANXIETY; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG INHIBITION; DRUG MECHANISM; FEMALE; MALE; MATERNAL DEPRIVATION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; TRANQUILIZING ACTIVITY; ULTRASOUND; VOCALIZATION;

ANIMAL COMMUNICATION; ANIMALS; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANXIETY; FEMALE; MALE; RATS; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; RECEPTORS, VASOPRESSIN; SOCIAL ISOLATION; ULTRASONICS;

ANIMALIA; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 31844433733     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2005.11.005     Document Type: Article

References (31)

1. G. Aguilera, and C. Rabadan-Diehl Vasopressinergic regulation of the hypothalamic-pituitary-adrenal axis: implications for stress adaptation Regul Pept 96 2000 23 29
2. T.M. Ballard, M.L. Woolley, E. Prinssen, J. Huwyler, R. Porter, and W. Spooren The effect of the mGlu5 receptor antagonist MPEP in rodent tests of anxiety and cognition: a comparison Psychopharmacology (Berl) 179 2005 218 229
3. F. Borsini, J. Podhorna, and D. Marazziti Do animal models of anxiety predict anxiolytic-like effects of antidepressants? Psychopharmacology (Berl) 163 2002 121 141
4. J. Brodkin, C. Busse, S.J. Sukoff, and MA. Varney Anxiolytic-like activity of the mGluR5 antagonist MPEP a comparison with diazepam and buspirone Pharmacol Biochem Behav 73 2002 359 366
5. S. Chaki, A. Nakazato, L. Kennis, M. Nakamura, C. Mackie, and M. Sugiura Anxiolytic- and antidepressant-like profile of a new CRF1 receptor antagonist, R278995/CRA0450 Eur J Pharmacol 485 2004 145 158
6. A. Dirks, E.W. Fish, T. Kikusui, J. van der Gugten, L. Groenink, and B. Olivier Effects of corticotropin-releasing hormone on distress vocalizations and locomotion in maternally separated mouse pups Pharmacol Biochem Behav 72 2002 993 999
7. B. Dow, and N. Kline Antidepressant treatment of posttraumatic stress disorder and major depression in veterans Ann Clin Psychiatry 9 1997 1 5
8. D.P. Figgitt, and KJ. McClellan Fluvoxamine. An updated review of its use in the management of adults with anxiety disorders Drugs 60 2000 925 954
9. CR. Gardner Distress vocalization in rat pups. A simple screening method for anxiolytic drugs J Pharmacol Methods 14 1985 181 187
10. G. Griebel, J. Simiand, C. Serradeil-Le Gal, J. Wagnon, M. Pascal, and B. Scatton Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders Proc Natl Acad Sci U S A 99 2002 6370 6375
11. M. Hascoet, M. Bourin, M.C. Colombel, A.J. Fiocco, and GB. Baker Anxiolytic-like effects of antidepressants after acute administration in a four-plate test in mice Pharmacol Biochem Behav 65 2000 339 344
12. S. Hashimoto, T. Inoue, and T. Koyama Serotonin reuptake inhibitors reduce conditioned fear stress-induced freezing behavior in rats Psychopharmacology (Berl) 123 1996 182 186
13. S.C. Heinrichs, E.B. De Souza, G. Schulteis, J.L. Lapsansky, and D.E. Grigoriadis Brain penetrance, receptor occupancy and antistress in vivo efficacy of a small molecule corticotropin releasing factor type I receptor selective antagonist Neuropsychopharmacology 27 2002 194 202
14. T.R. Insel, J.L. Hill, and R.B. Mayor Rat pup ultrasonic isolation calls: possible mediation by the benzodiazepine receptor complex Pharmacol Biochem Behav 5 1986 1263 1267
15. S. Kasper, Y. Pletan, A. Solles, and A. Tournoux Comparative studies with milnacipran and tricyclic antidepressants in the treatment of patients with major depression: a summary of clinical trial results Int Clin Psychopharmacol Suppl 4 1996 35 39
16. M. Katzman Venlafaxine in the treatment of anxiety disorders Expert Rev Neurother 4 2004 371 381
17. J.H. Kehne, T.C. McCloskey, B.M. Baron, E.M. Chi, B.L. Harrison, and J.P. Whitten NMDA receptor complex antagonists have potential anxiolytic effects as measured with separation-induced ultrasonic vocalizations Eur J Pharmacol 193 1991 283 292
18. J.H. Kehne, S. Coverdale, T.C. McCloskey, D.C. Hoffman, and J.V. Cassella Effects of the CRF(1) receptor antagonist, CP154,526, in the separation-induced vocalization anxiolytic test in rat pups Neuropharmacology 39 2000 1357 1367
19. J. Miyamoto, M. Tsuji, H. Takeda, M. Ohzeki, H. Nawa, and T. Matsumiya Characterization of the anxiolytic-like effects of fluvoxamine, milnacipran and risperidone in mice using the conditioned fear stress paradigm Eur J Pharmacol 504 2004 97 103
20. C. Moret, M. Charveron, J.P. Finberg, J.P. Couzinier, and M. Briley Biochemical profile of midalcipran (F 2207), 1-phenyl-1-diethyl-aminocarbonyl-2- aminomethyl-cyclopropane (Z) hydrochloride, a potential fourth generation antidepressant drug Neuropharmacology 24 1985 1211 1219
21. B. Olivier, H.E. Molewijk, J.A. van der Heyden, R. van Oorschot, E. Ronken, and J. Mos Ultrasonic vocalizations in rat pups: effects of serotonergic ligands Neurosci Biobehav Rev 23 1998 215 227
22. B. Olivier, E. Molewijk, R. van Oorschot, J. van der Heyden, E. Ronken, and J. Mos Rat pup ultrasonic vocalization: effects of benzodiazepine receptor ligands Eur J Pharmacol 358 1998 117 128
23. M.E. Page, P. Szeliga, F. Gasparini, and J.F. Cryan Blockade of the mGlu5 receptor decreases basal and stress-induced cortical norepinephrine in rodents Psychopharmacology (Berl) 179 2005 240 246
24. C. Rivier, and P.M Plotsky Mediation by corticotropin-releasing factor (CRF) of adrenohypophysial hormone secretion Annu Rev Physiol 48 1986 475 494
25. A.F. Schatzberg New indications for antidepressants J Clin Psychiatry 61 Suppl 11 2000 9 17
26. C. Serradeil-Le Gal, J. Wagnon, J. Simiand, G. Griebel, C. Lacour, and G. Guillon Characterization of (2S,4R)-1-[5-chloro-1-[(2,4-dimethoxyphenyl) sulfonyl]-3-(2-methoxy-phenyl)-2-oxo-2,3-dihydro-1H-indol-3-yl]-4-hydroxy-N, N-dimethyl-2-pyrrolidine carboxamide (SSR149415), a selective and orally active vasopressin V1b receptor antagonist J Pharmacol Exp Ther 300 2002 1122 1130
27. P.H. Silverstone Qualitative review of SNRIs in anxiety J Clin Psychiatry 65 Suppl 17 2004 19 28
28. W.P. Spooren, F. Gasparini, T.E. Salt, and R. Kuhn Novel allosteric antagonists shed light on mglu(5) receptors and CNS disorders Trends Pharmacol Sci 22 2001 331 337
29. L.K. Takahashi Ontogeny of behavioral inhibition induced by unfamiliar adult male conspecifics in preweanling rats Physiol Behav 52 1992 493 498
30. L.D. Van de Kar, and M.L. Blair Forebrain pathways mediating stress-induced hormone secretion Front Neuroendocrinol 20 1999 1 48
31. J.T. Winslow, and T.R. Insel Serotonergic and catecholaminergic reuptake inhibitors have opposite effects on the ultrasonic isolation calls of rat pups Neuropsychopharmacology 3 1990 51 59